Modern Environmental Exposures

 

The Disruptive Influence of Modern Environmental Exposures on the Human Metagenomic and Epigenetic Profiles

The modern human experience is characterized by a myriad of environmental exposures that profoundly influence biology's metagenomic and epigenetic landscapes. These exposures, ranging from pollutants and dietary additives to microplastics, antibiotics, and lifestyle factors, interact with our biological systems in complex ways, affecting the microbial communities inhabiting the human body (the metagenome) and the regulation of our genes (epigenetics) (“The Integrative Human Microbiome Project,” 2019). This intersection of environmental factors and our biological processes contributes to a heightened risk of chronic diseases, including metabolic syndromes, cancers, autoimmune disorders, and neurodegenerative diseases (Sargis et al., 2019).

Environmental pollutants, such as air pollution, heavy metals, and particulate matter, are significant disruptors of the human microbiome (Magueresse‐Battistoni et al., 2018). These pollutants can directly impact the composition and diversity of microbial communities in the gut, skin, and respiratory tract, leading to dysbiosis and compromising immune function and metabolic homeostasis (Magueresse‐Battistoni et al., 2018)(Sargis et al., 2019). Heavy metals, for instance, have toxic effects on gut bacteria, impairing their ability to produce critical short-chain fatty acids that maintain gut barrier integrity and systemic anti-inflammatory responses (Genuis et al., 2013) (Sargis et al., 2019).

Antibiotics and other pharmaceuticals also have a major environmental influence on metagenome (“The Integrative Human Microbiome Project,” 2019). While essential for combating infections, their overuse and misuse can disrupt microbial ecosystems, leading to the proliferation of antibiotic-resistant bacteria and a reduction in beneficial microbial populations (“The Integrative Human Microbiome Project,” 2019). These changes not only impair the microbiome's ability to support immune function but also contribute to a range of chronic conditions, from inflammatory bowel disease to cardiovascular disorders and type 2 diabetes (Magueresse‐Battistoni et al., 2018) (“The Integrative Human Microbiome Project,” 2019) (Alam et al., 2017).

Beyond the microbiome, environmental exposures can also significantly impact the human epigenome, altering the regulation of gene expression and contributing to disease pathogenesis. Preclinical and clinical evidence suggests that chronic stress and trauma can lead to epigenetic modifications, particularly DNA methylation, which may underlie the development of various psychopathologies. The profound influence of modern environmental exposures on the human metagenomic and epigenetic profiles underscores the need for a comprehensive understanding of these complex interactions. Elucidating the mechanisms by which environmental factors shape the microbiome and gene regulation will be crucial for developing effective strategies to mitigate the rising burden of chronic diseases (Tang & Hazen, 2014) (Sargis et al., 2019).

Aside from the direct impacts on the microbiome, environmental exposures can also induce epigenetic changes that contribute to disease risk. Pollutants, dietary factors, and lifestyle behaviors can alter the expression of genes involved in immune function, metabolism, and cellular processes, leading to long-term consequences for human health (Sanz et al., 2018) (Magueresse‐Battistoni et al., 2018).

Ultimately, the interplay between environmental exposures, the metagenome, and the epigenome represents a dynamic and multifaceted system that profoundly influences human physiology and disease susceptibility. Understanding and addressing these complex relationships will be critical for promoting overall health and well-being in the modern environmental landscape.

The implications of this environmental-biological interplay are far-reaching. Developing effective interventions to rehabilitate perturbed microbial ecosystems and mitigate the epigenetic consequences of environmental exposures holds immense promise for preventing and managing chronic diseases (Durack & Lynch, 2018) (Thoda & Touraki, 2023).

One promising intervention avenue is using probiotics and their derived bioactive compounds. These microorganisms and their metabolites have demonstrated immunomodulatory properties, suggesting their potential to restore gut homeostasis and dampen the inflammatory processes underlying many chronic conditions (Thoda & Touraki, 2023).

As our understanding of the human microbiome and epigenome continues to evolve, the opportunities to leverage these insights for improved health outcomes will become increasingly apparent. Embracing a holistic, systems-level approach to environmental health will empower individuals and communities to navigate the complex web of modern environmental exposures and their impacts on human biology.

In addition, the role of the gut microbiome in modulating host health and its potential for preventive and therapeutic applications warrants further exploration (Durack & Lynch, 2018). Strategies for manipulating the gut microbiome, such as dietary modulation, prebiotic and probiotic supplementation, and fecal microbiota transplantation, may offer promising avenues for managing or preventing chronic inflammatory conditions (Zhang et al., 2019).

The complex interplay between environmental exposures, the human metagenome, and epigenetic regulation represents a significant frontier in understanding and addressing the rising burden of chronic diseases. Continued research in this field will be essential for developing comprehensive, individualized approaches to promoting overall health and resilience in the face of the modern environmental landscape.

The modern environmental landscape poses significant challenges to human health, profoundly impacting individuals' metagenomic and epigenetic profiles. Addressing these complex interactions will be crucial for mitigating the rising prevalence of chronic diseases and improving overall well-being.

Several key areas for future research and action emerge from this examination of the environmental-biological interplay:

  • Elucidating how environmental factors, such as pollutants, pharmaceuticals, and lifestyle behaviors, shape the human microbiome and epigenome and the downstream consequences for physiological processes and disease risk.

  • Effective interventions should be developed, including probiotics, prebiotics, and fecal microbiota transplantation, to rehabilitate perturbed microbial ecosystems and dampen the inflammatory processes underlying chronic diseases.

  • Exploring the potential of precision medicine approaches incorporating microbiome and epigenetic data to stratify patients and personalize preventive and therapeutic strategies.

  • Advocating for policy and regulatory changes that promote environmental sustainability and mitigate the negative impacts of modern exposures on human and planetary health.

Integrating environmental, metagenomic, and epigenetic factors represents a critical frontier for advancing our understanding of human health and disease. By embracing a holistic, systems-level approach, we can empower individuals and communities to navigate the complex web of modern environmental exposures and their impacts on our biology, ultimately paving the way for a healthier, more resilient future.

The complex interplay between these environmental and biological factors has far-reaching implications for human health, underscoring the need for a multifaceted approach to addressing the rising burden of chronic diseases. One key aspect of this multifaceted approach is the need to better understand how environmental factors, such as pollutants and lifestyle behaviors, shape the human microbiome and epigenome (Gilbert et al., 2018) (Durack & Lynch, 2018). Advances in high-throughput sequencing and other analytical tools have greatly expanded our knowledge of the gut microbiome and its role in modulating host health (Gibbons, 2019) (Zhang et al., 2019).

However, much remains to be learned about the precise pathways through which environmental exposures disrupt microbial communities and alter epigenetic regulation, leading to physiological changes and increased disease susceptibility.

Strategies for manipulating the gut microbiome, such as dietary modulation, prebiotic and probiotic supplementation, and fecal microbiota transplantation, have shown promise in addressing the inflammatory processes underlying many chronic conditions (Zhang et al., 2019) (Sanz et al., 2018).

Another key area for exploration is the potential of precision medicine approaches that incorporate microbiome and epigenetic data to stratify patients and personalize preventive and therapeutic strategies (Gilbert et al., 2018). By tailoring interventions to the unique characteristics of an individual's environmental exposures, metagenomic profile, and epigenetic landscape, clinicians may be able to more effectively mitigate the health impacts of modern environmental challenges.

Addressing the complex interplay between environmental, metagenomic, and epigenetic factors will require a multidisciplinary, systems-level approach. Policy and regulatory changes that promote environmental sustainability and mitigate the negative impacts of modern exposures on human and planetary health will be crucial complements to clinical and research efforts (Durack & Lynch, 2018).

Further research is needed to fully elucidate the mechanisms underlying the complex interactions between environmental factors, the human metagenome, and epigenetic regulation. Nonetheless, the existing evidence underscores the urgent need to address these challenges and develop comprehensive, individualized approaches to promoting overall health and resilience in the face of the modern environmental landscape.

The modern environmental landscape, characterized by exposures to pollutants, dietary additives, microplastics, antibiotics, pesticides, and lifestyle factors such as stress and sedentary behavior, has profound implications for human health. These environmental exposures can significantly disrupt individuals' metagenomic and epigenetic profiles, leading to changes in physiological processes and increased disease risk.

One key aspect of this environmental-biological interplay is the impact on the human microbiome. Environmental pollutants, such as air pollution, heavy metals, and particulate matter, can directly affect the composition and diversity of microbial communities in the gut, skin, and respiratory tract, leading to dysbiosis and chronic low-grade inflammation (Durack & Lynch, 2018). This microbiome disruption has been linked to a range of chronic diseases, including inflammatory bowel disease, cardiovascular disorders, and type 2 diabetes (Durack & Lynch, 2018).

The intersection of these environmental factors with our biological systems represents a critical frontier for advancing our understanding of human health and disease. By embracing a holistic, systems-level approach, we can empower individuals and communities to navigate the complex web of modern environmental exposures and their impacts on our biology, ultimately paving the way for a healthier, more resilient future. (Durack & Lynch, 2018) (Zhang et al., 2024) (Alam et al., 2017) (Sanz et al., 2018)

Emerging research also suggests that exposure to natural environments, such as green spaces, may shape the human microbiota and promote overall health. The "biodiversity hypothesis" posits that contact with diverse microbial communities in natural settings can contribute to developing a more robust and resilient human microbiome, potentially offering protection against the negative health effects of modern environmental stressors. (Zhang et al., 2024)

The profound influence of the modern environmental landscape on the human metagenome and epigenome represents a critical challenge for public health and biomedical research. By elucidating the mechanisms underlying these complex interactions, we can develop more effective strategies for promoting individual and community resilience, mitigating the burden of chronic disease, and ensuring a healthier, more sustainable future for future generations. (“The Integrative Human Microbiome Project,” 2019) (Durack & Lynch, 2018)

A multifaceted approach that integrates research, policy, and community-level interventions is needed to address this challenge further. Policy and regulatory changes that prioritize environmental sustainability, limit the use of harmful chemicals and pollutants, and promote access to natural spaces can help mitigate the negative impacts of modern exposures on human health. (Durack & Lynch, 2018)

In addition to policy and regulatory measures, community-level interventions that promote healthy lifestyles and environmental stewardship can also play a crucial role in addressing the complex interplay between the modern environment and human biology.

Integrating environmental, metagenomic, and epigenetic approaches holds tremendous promise for advancing personalized and precision medicine. It will enable clinicians to develop tailored interventions that address the unique factors shaping an individual's health trajectory. Ultimately, tackling the challenges the modern environmental landscape poses will require a concerted, multidisciplinary effort that spans research, policy, and community-based initiatives. (Blaser et al., 2016)

References

  1. Alam, R., Abdolmaleky, H. M., & Zhou, J. (2017). Microbiome, inflammation, epigenetic alterations, and mental diseases [Review of Microbiome, inflammation, epigenetic alterations, and mental diseases]. American Journal of Medical Genetics Part B Neuropsychiatric Genetics, 174(6), 651. Wiley. https://doi.org/10.1002/ajmg.b.32567

  2. Blaser, M. J., Cardon, Z. G., Cho, M. K., Dangl, J. L., Donohue, T. J., Green, J. L., Knight, R., Maxon, M. E., Northen, T. R., Pollard, K. S., & Brodie, E. (2016). Toward a Predictive Understanding of Earth’s Microbiomes to Address 21st Century Challenges. In M. J. Blaser, Z. G. Cardon, M. K. Cho, J. L. Dangl, T. J. Donohue, J. L. Green, R. Knight, M. E. Maxon, T. R. Northen, K. S. Pollard, & E. Brodie, mBio (Vol. 7, Issue 3). American Society for Microbiology. https://doi.org/10.1128/mbio.00714-16

  3. Durack, J., & Lynch, S. V. (2018). The gut microbiome: Relationships with disease and opportunities for therapy [Review of The gut microbiome: Relationships with disease and opportunities for therapy]. The Journal of Experimental Medicine, 216(1), 20. Rockefeller University Press. https://doi.org/10.1084/jem.20180448

  4. Genuis, S. J., Sears, M., Schwalfenberg, G., Hope, J., & Bernhoft, R. A. (2013). Clinical Detoxification: Elimination of Persistent Toxicants from the Human Body. In S. J. Genuis, M. Sears, G. Schwalfenberg, J. Hope, & R. A. Bernhoft, The Scientific World JOURNAL (Vol. 2013, Issue 1). Hindawi Publishing Corporation. https://doi.org/10.1155/2013/238347

  5. Gibbons, S. M. (2019). Defining Microbiome Health through a Host Lens. In S. M. Gibbons, mSystems (Vol. 4, Issue 3). American Society for Microbiology. https://doi.org/10.1128/msystems.00155-19

  6. Gilbert, J. A., Blaser, M. J., Caporaso, J. G., Jansson, J., Lynch, S. V., & Knight, R. (2018). Current understanding of the human microbiome [Review of Current understanding of the human microbiome]. Nature Medicine, 24(4), 392. Nature Portfolio. https://doi.org/10.1038/nm.4517

  7. Magueresse‐Battistoni, B. L., Vidal, H., & Naville, D. (2018). Environmental Pollutants and Metabolic Disorders: The Multi-Exposure Scenario of Life [Review of Environmental Pollutants and Metabolic Disorders: The Multi-Exposure Scenario of Life]. Frontiers in Endocrinology, 9. Frontiers Media. https://doi.org/10.3389/fendo.2018.00582

  8. Sanz, Y., Romaní‐Pérez, M., Benítez‐Páez, A., Portune, K., Brigidi, P., Rampelli, S., Dinan, T. G., Stanton, C., Delzenne, N. M., Blachier, F. F., Neyrinck, A. M., Beaumont, M., Olivares, M., Holzer, P., Günther, K., Wolters, M., Ahrens, W., Claus, S. P., Campoy, C., … Kamp, J. W. van der. (2018). Towards microbiome-informed dietary recommendations for promoting metabolic and mental health: Opinion papers of the MyNewGut project. In Y. Sanz, M. Romaní‐Pérez, A. Benítez‐Páez, K. Portune, P. Brigidi, S. Rampelli, T. G. Dinan, C. Stanton, N. M. Delzenne, F. F. Blachier, A. M. Neyrinck, M. Beaumont, M. Olivares, P. Holzer, K. Günther, M. Wolters, W. Ahrens, S. P. Claus, C. Campoy, … J. W. van der Kamp, Clinical Nutrition (Vol. 37, Issue 6, p. 2191). Elsevier BV. https://doi.org/10.1016/j.clnu.2018.07.007

  9. Sargis, R. M., Heindel, J. J., & Padmanabhan, V. (2019). Interventions to Address Environmental Metabolism-Disrupting Chemicals: Changing the Narrative to Empower Action to Restore Metabolic Health [Review of Interventions to Address Environmental Metabolism-Disrupting Chemicals: Changing the Narrative to Empower Action to Restore Metabolic Health]. Frontiers in Endocrinology, 10. Frontiers Media. https://doi.org/10.3389/fendo.2019.00033

  10. Tang, W. H. W., & Hazen, S. L. (2014). The contributory role of gut microbiota in cardiovascular disease [Review of The contributory role of gut microbiota in cardiovascular disease]. Journal of Clinical Investigation, 124(10), 4204. American Society for Clinical Investigation. https://doi.org/10.1172/jci72331

  11. The Integrative Human Microbiome Project. (2019). In Nature (Vol. 569, Issue 7758, p. 641). Nature Portfolio. https://doi.org/10.1038/s41586-019-1238-8

  12. Thoda, C., & Touraki, M. (2023). Immunomodulatory Properties of Probiotics and Their Derived Bioactive Compounds. In C. Thoda & M. Touraki, Applied Sciences (Vol. 13, Issue 8, p. 4726). Multidisciplinary Digital Publishing Institute. https://doi.org/10.3390/app13084726

  13. Zhang, Y., Zhou, G.-L., Wang, L., Browning, M. H. E. M., Markevych, I., Heinrich, J., Knibbs, L. D., Zhao, T., Ding, Y., Chen, S., Liu, K., Dadvand, P., Dong, G., & Yang, B. (2024). Greenspace and human microbiota: A systematic review [Review of Greenspace and human microbiota: A systematic review]. Environment International, 187, 108662. Elsevier BV. https://doi.org/10.1016/j.envint.2024.108662

  14. Zhang, Z., Tang, H., Chen, P., Xie, H., & Tao, Y. (2019). Demystifying the manipulation of host immunity, metabolism, and extraintestinal tumors by the gut microbiome [Review of Demystifying the manipulation of host immunity, metabolism, and extraintestinal tumors by the gut microbiome]. Signal Transduction and Targeted Therapy, 4(1). Springer Nature. https://doi.org/10.1038/s41392-019-0074-5